1 / 19

Soft Tissue Sarcoma

Soft Tissue Sarcoma. Craig Blum, M.D. Soft Tissue Sarcoma. Arise from embyronic mesoderm Ecoderm- skin Endoderm- guts Mesoderm- skeleton and muscles, connective tissue. Osteosarcoma Chondrosarcoma GIST Ewing Sarcoma. Fibrosarcoma Liposarcoma Rhabdomyosarcoma Epitheloid Sarcoma

orsen
Télécharger la présentation

Soft Tissue Sarcoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Soft Tissue Sarcoma Craig Blum, M.D.

  2. Soft Tissue Sarcoma • Arise from embyronic mesoderm • Ecoderm- skin • Endoderm- guts • Mesoderm- skeleton and muscles, connective tissue

  3. Osteosarcoma Chondrosarcoma GIST Ewing Sarcoma Fibrosarcoma Liposarcoma Rhabdomyosarcoma Epitheloid Sarcoma Desmoplastic small round cell tumor Histologic Types

  4. Incidence • Rare tumors • 2007: • 9200 US • 3560 deaths • colon 112,000 • lung 214,000

  5. Cause • Unclear: • Genetic factors: chromosomal abnormalities • Radiation: long latency • Chemical exposure: industrial agents • Lymphedema: **absite • lymphangiosarcomas

  6. Classification • Best predictor of a sarcoma’s biologic aggressiveness / metastatic potential is GRADE • Cellularity, nuclear atypia, degree of necrosis, mitotic activity. • Subjectivity (40%)

  7. Clinical • Asymptomatic mass • 38% large than 10cm at presentation • Imaging: • MRI versus CT • PET

  8. Pearl • Few sarcomas metastasize to lymph nodes • Extremity  Lung • Abdominal  Liver then lung

  9. Biopsy • <5 cm: excisional biopsy with clear margins • >5cm: incisional or core needle bx (CNB) • Don’t use FNA bc sample too small

  10. Treatment • Surgical Tx is foundation of treatment of STS • LSS standard of care • Amputation reserved for cancers that involve major vessels, bones, nerves such that function would be compromised.

  11. Surgical Management • Goal margin 1 -2 cm when possible. • Regional lymphadenectomy is NOT usually indicated bc only 2.6% sarcomas metastasize to LN • Rhabdomyosarcoma • Epitheloid sarcoma (CT of hands) • Clear cell sarcoma (tendons) • Synovial sarcoma • Vascular sarcoma

  12. Radiation • Take home: • [prospective, randomized trails] demonstrated adjuvant radiotherapy helped prevent local recurrence in pts with high grade STS. • However, did not demonstrate improved overall survival. • [retrospective studies] <5cm (small) STS may be resected with negative margins alone.

  13. Chemo • Take home: • “At present, given the uncertainty regarding its efficacy, postoperative adjuvant chemotherapy for treatment of STS is probably best employed in the context of appropriate clinical trials.” • Preop “theoretical advantages” but again, insufficient evidence for any survival benefit.

  14. Targeted Therapy • Targeted tyrosine kinase receptor c-kit for treating GIST

  15. Hyperthermic Isolated Limb Perfusion • Pts where LSS is not possible initially • May make it possible to resect with a negative margin. • Not well established in US

  16. Metastatic Disease • Pulmonary mets are present in 20% of pts with trunk of extremity sarcomas. • Medically fit, no extrathoracic dx, mets resectable  pulmonary metastasectomy. • MSKCC study

  17. Rhabdomyosarcoma • most common soft tissue sarcoma in infants and children • head and neck; around the eyes -- 35-40% • GU tract -- 20% • extremities -- 15-20% • trunk -- 10-15%

More Related